PD-L1 Targeting Molecular Imaging of Solid Tumors

NCT04629326 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University Cancer Hospital & Institute